BCX-34: Began Phase I/II trial

BioCryst Pharmaceuticals Inc. (BCRX), Birmingham, Ala. Product: BCX-34, small molecule inhibitor of purine nucleoside phosphorylase, an enzyme that plays a central role in T cell proliferation Indica...